Monkey neurovirulence test for live mumps vaccine

Biologicals

Volumn 24, Issue 3, 1996, Pages 223-224

  Maximova, Olga ^b   Dragunsky, Eugenia ^a   Taffs, Rolf ^a   Snoy, Philip ^a   Cogan, John ^a   Marsden, Susan ^c   Levenbook, Inessa ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b Tarasevic State Institute for the Standardization and Control of Medical Biological Preparations   (France)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MUMPS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN VENTRICLE; HEMISPHERE; HUMAN; INFLAMMATION; INTRACEREBRAL DRUG ADMINISTRATION; MENINGITIS; METHODOLOGY; MONKEY; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRULENCE;

EID: 17344388119     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1996.0030     Document Type: Article

References (3)

1. 1. Requirements for measles, mumps and rubella vaccines and combined vaccine (live). WHO Techl Rep Ser, 1994; 840; 100-127.
2. 2. U.S. Code of Federal Regulations. Title 21, Part 630, Subpart F-Mumps Virus Vaccine Live. Washington DC: U.S. Government Printing Office, 1995.
3. 3. Levenbook IS, Nikolaeva MA, Chigirinsky AE, Ralf NM, Kozlov VG, Vardanyan NV, Sliopushkina VG, Kolomiets OL, Rukhamina ML, Grigoryeva LV. On the morhological evaluation of the neurovirulence safety of attenuated mumps virus strains in monkeys. J Biol Stand 1979; 7: 9-19.